Just announced at
#CIIE2019
, we signed an MOU to create a new Global R&D facility & an AI Innovation Centre in Shanghai to develop potential new medicines for China and the rest of the world, as well as investment fund with partners to drive innovation.
Our new R&D and AI centres in Shanghai, announced at
#CIIE2019
, expands our scientific focus in China and reinforces our commitment to partnership and improving healthcare in the country and around the world.
In response to
#COVID19
, teams across AstraZeneca have moved quickly to maintain continuity of care, contribute to society, and use our scientific expertise to fight the pandemic.
In 2020, teams across AstraZeneca have risen to the challenges
#COVID19
has posed to global health. Today’s advancement is a significant step forward in the fight against this pandemic.
#WhatScienceCanDo
Around the world we’ve seen the
#COVID19
pandemic disrupt
#cancer
care for millions. In partnership with the global cancer community we are urging people to investigate possible cancer symptoms and return to cancer care services.
#NewNormalSameCancer
#COVID19
is having a negative impact on
#ovariancancer
diagnoses. Now more than ever, we're working with the healthcare community for better outcomes. Watch the full film which celebrates the lives of 8 women years after diagnosis:
#NewNormalSameCancer
We are deeply saddened by the news that José Baselga, EVP Oncology R&D, has passed away. An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca. We send our condolences to his family.
Thanks to
@HHSGov
@SecAzar
we’re proud to announce US commitments for
@UniofOxford
#COVID19
vaccine, as we are working on a number of agreements in parallel to ensure broad & equitable supply throughout the world at no profit during the pandemic.
One year ago this week, we joined forces with
@UniofOxford
to tackle
#COVID19
. The world has changed significantly since then and together with our partners we have worked tirelessly to help communities around the globe impacted by the pandemic.
#WorldImmunizationWeek
#COVID19
has disrupted cancer care for millions worldwide with diagnoses in 2020 falling by approximately 40% and likely worsening. Together with the oncology community, we urge people to contact their doctor, return to screening and prioritise cancer care.
#NewNormalSameCancer
We have reached an agreement with the Inclusive Vaccines Alliance to supply up to 400 million doses of
@UniofOxford
’s potential
#COVID19
vaccine to Europe at no profit
For a vaccine to progress from inception to authorisation in less than 12 months demonstrates
#WhatScienceCanDo
. The collective efforts and dedication from everyone involved has made this monumental achievement possible.
We are pleased to honor Tonya Villafana on becoming elected as a New Fellow of the International Society of Vaccines (ISV) in recognition of her pioneering efforts to help defeat
#COVID19
, and her notable contributions to combating infectious diseases for populations in need.
To all the
#COVID19
vaccine clinical trial participants, scientists and clinicians – we thank you. As a result of your involvement, we are progressing at pace, learning more about this virus and what needs to be done to help end the pandemic.
We are named a global sustainability leader by the 2018 Dow Jones Sustainability Index. We received industry top scores in the areas Environmental Reporting, Labour Practice Indicators, and Health Outcome Contribution
#sustainability
#DJSI
#ESG
@RobecoSAM
We recently released data from our COVID-19 vaccine US Phase III trial. We maintain our commitment to supplying our vaccine broadly and equitably at no profit during the pandemic.
To support healthcare workers around the world fighting the
#COVID19
global pandemic, we are donating 9 million face masks, finding ways to speed up diagnosis and exploring possible monoclonal antibody treatments.
A
#COVID19
vaccine is crucial to helping overcome this global pandemic. That is why we are partnering with
@UniofOxford
to support the global development, manufacturing and distribution of the University’s vaccine candidate if it proves to be effective.
Today, we welcome the positive opinion from the CHMP of the European Medicines Agency on our
#COVID19
vaccine, and we await EU conditional marketing authorisation.
We have been steadily laying the groundwork required for the swift supply of our potential
#COVID19
vaccine, should it receive regulatory approval. We pledge to provide broad, timely and equitable access to the vaccine and we are poised to deliver.
As a key partner in the global
#COVAX
Facility, we’ve supplied more than 37m doses to 100 countries in just over a month, with many more to come. We’re committed to broad, equitable access - the majority of these countries are LMICs.
#Anaemia
is a common complication of chronic
#kidney
disease caused by low levels of haemoglobin in the blood. Our survey of
#CKD
patients with anaemia revealed how patients perceive and understand their disease.
At the heart of our core values is to “follow the science” and we are committed to adhere to the highest scientific and clinical standards as we research a potential
#COVID19
vaccine.
@Sanofi
will you join us as
#WeStandWithScience
?
#JNJ
is proud to share our commitment to upholding the integrity of the scientific process in the development of a
#COVID19
vaccine. Rigorous science and safety must be the priority in vaccine development.
#WeStandWithScience
, and encourage
@AstraZeneca
to stand with us.
We're pleased to announce the appointment of Dr.
@susanmgalbraith
as EVP, Oncology R&D following the passing of José Baselga earlier this year. Susan is an outstanding oncologist with a track record of delivering breakthrough science over the past decade at AstraZeneca.
Many future scientific breakthroughs will result from the use of new technologies. As a result, the therapies of tomorrow will be different from those of today. We’re on a quest to transform and, ultimately, cure
#respiratory
diseases: .
#ERSCongress
2019 was a year of continued progress - both in the innovative medicines we develop and deliver, and in the positive changes we are making for our planet. $AZN
Ahead of the G7, Pascal Soriot met with HRH The Prince of Wales and fellow members of
@TheSMI
to discuss how the public and private sector can collaborate to accelerate the transition towards a sustainable future.
Our new global R&D facility - The Discovery Centre (DISC) - in
#Cambridge
, UK exemplifies our belief in
#WhatScienceCanDo
. It demonstrates our dynamic and innovative approach to R&D and our commitment to delivering breakthroughs that will benefit patients around the world.
We are collaborating with world leading experts to help develop a registry-based clinical trial (R-RCT) to gain learnings and experiences that can be applied to future trials and drive innovation.
#Asthma
is a common, yet complex, chronic condition impacting 339 million people globally. Often patients who have
#severeasthma
get mischaracterised as having asthma. Our expert shares more in
@TheEconomist
: .
#ERSCongress
In the fight against
#COVID19
, it is imperative to develop vaccines that will work in a real-world setting. Here’s what is needed to overcome the pandemic:
Congratulations to Pascal Soriot, AstraZeneca CEO, who has been awarded a knighthood for services to UK life sciences and leadership in the global response to the COVID-19 pandemic.
To address the urgent crisis in India, we are pledging humanitarian aid that will provide oxygen concentrators, medicines, PPE and other supplies via
@DirectRelief
. We also remain focused on fair, equitable access to vaccination to help end the pandemic.
Together with our partners,
@gavi
@WHO
@CEPIvaccines
, we are doing everything possible to ensure people around the world have access to safe, effective Covid-19 vaccines, wherever they live and regardless of income level. More from CEO Pascal Soriot:
Today marks an historic milestone in the global fight against the
#COVID19
pandemic with the first COVAX delivery to Ghana. We look forward to our continued collaboration with
@GAVI
@CEPIvaccines
@UNICEF
as we deliver on our commitment to broad, equitable access of our vaccine.
"The next phase in the fight against this disease can begin – the ramping up of the largest immunization campaign in history."
@unicefchief
on the first shipment of COVID-19 vaccines by the COVAX Facility.
We have just announced continued strong top-line performance for Q3 2019 underpinning confidence in sustainable growth. View our Q3 2019
#Results
here:
We are deeply saddened by the passing of Her Majesty Queen Elizabeth II and extend our condolences to her family and all those in the United Kingdom and around the world whose lives she touched.
Are you a patient or caregiver non-profit organisation with ideas on how to improve outcomes for people living with or at risk of
#lungcancer
? We want to hear from you.
#LCAM
#LungAmbition
Evolving our scientific understanding of inflammation is a priority for us at AstraZeneca. The aim of this work is to deliver scientific breakthroughs that transform the lives of people with
#asthma
: .
#ERSCongress
Huge congratulations to
@MenePangalos
, EVP BioPharmaceuticals R&D, who has been awarded a knighthood by Her Majesty The Queen in the New Year 2020 Honours List. The award recognises Mene’s services to UK science:
#NewYearsHonours
Together with
@GSK
and
@Cambridge_Uni
, we have formed a collaboration to support the UK Government’s effort to boost testing for
#COVID19
. A new testing facility will be set up at the University’s Anne McLaren laboratory to support this national effort.
We are making our science and business sustainable. The Discovery Centre (DISC) in
#Cambridge
, UK, is designed to strengthen collaboration, promote openness, and improve the sustainability of our R&D, science and business operations.
#WhatScienceCanDo
Today we’re announcing results from 2020 – a year in which we saw double digit growth as we continued to advance our pipeline and deliver for patients. $AZN
We join
@adarpoonawalla
in offering our deepest condolences to those impacted by today's tragic fire and extend our ongoing support to
@SerumInstIndia
in the fight against
#COVID19
.
I would like to reassure all governments & the public that there would be no loss of
#COVISHIELD
production due to multiple production buildings that I had kept in reserve to deal with such contingencies at
@SerumInstIndia
. Thank you very much
@PuneCityPolice
& Fire Department
As we announce our first half results and company progress today, we are particularly proud of the continued supply of our medicines to millions of patients throughout the
#COVID19
pandemic. $AZN
In acquiring
@AlexionPharma
, we’ll enhance our presence in immunology, rare diseases and precision medicines to drive innovation that delivers life-changing medicines to patients - Pascal Soriot, CEO $AZN $ALXN
Although we are recognised as one of the world’s 100 most sustainable companies, we still have a lot of work to do. Ambition Zero Carbon is our newly launched strategy to reach zero carbon by 2025 in operations, and that is only the beginning.
#WEF20
We are developing antibody drug conjugates (ADCs) to treat a range of tumour types, including breast, lung, and gastric cancers. ADCs directly deliver potent medicines to
#cancer
cells, while sparing healthy cells.
#ESMO21
Today, at the occasion of the visit of the Governor of São Paulo State, João Doria
@jdoriajr
, to
#Cambridge
(UK), we established a partnership for a strategic agreement of Innovation in Health at Hospital da Clínicas de São Paulo.
Today we announced results from a strong third quarter as we continue to execute our growth through innovation strategy. We remain on track to meet full-year guidance. $AZN
Watch the official trailer for a documentary celebrating the life and legacy of José Baselga – father, husband, colleague, mentor and
#cancer
’s fiercest opponent. Premiering March 2022.
We are committed to helping redefine cancer care by advancing innovative research, so that Suzanne and thousands of people diagnosed with ovarian cancer have the potential to achieve better outcomes and live their fullest lives possible. Learn about Suzanne’s experience below.
Many are turning the page on COVID-19 & returning to pre-pandemic life, but the story is different for immunocompromised (IC) people who aren’t protected by COVID-19 vaccination. It's vital that we prioritise the burden facing the IC community:
A viral pandemic requires the rapid manufacturing of effective treatments and vaccines. Manufacturing of vaccines needs to occur at scale and pace while maintaining consistent high standards and quality.
#whatsciencecando
When a virus enters the body, it invades human cells and replicates. When this happens, it sometimes changes a bit. This is normal for any virus. The changes are called mutations. A virus that has mutated is referred to as a
#variant
.
#whatsciencecando
Immunogenicity is complex measure of how well a vaccine works. As we learn more about the immune system response to the SARS-CoV-2 virus, this may be the key to understanding long-term vaccine effectiveness.
#WhatScienceCanDo
At a time that continues to challenge the world like never before, our commitment to advancing science for patients remains stronger than ever. See our full 2021 Q1 results here: $AZN
#COVID19
has had an enormous impact on cancer care. As we head into a new year, we reiterate our urgent message: Don’t wait. Contact your doctor. Get checked.
#NewNormalSameCancer
2022 was a year of continued strong company performance and execution of our long-term growth strategy. Looking ahead, we’ll deliver 15+ new medicines before the end of the decade. $AZN
Nearly one year ago, we lost a pioneering doctor who made a lasting impact on cancer research. Today “José Baselga: Cancer’s Fiercest Opponent” premieres to honour his legacy. Watch on
@TheAtlantic
:
#CancersFiercestOpponent
With an aim to decrease the impact of
#COVID19
, our R&D teams are working in collaboration with government and academia to identify monoclonal antibodies that have the potential to recognise, bind to and neutralise the SARS-CoV-2 virus.
Before
#COVID19
the oncology community was making incredible progress against
#cancer
but the pandemic endangers to erase years of progress, with diagnoses falling approximately 40% in 2020.We must act now. Don’t wait. Contact your doctor. Get checked.
#NewNormalSameCancer
Many factors determine the degree to which a vaccine is effective, including broad, timely and equitable access for those in need. This cornerstone of our
#COVID19
strategy has the potential to truly change the course of the pandemic.
Chronic
#kidneydisease
is a ‘silent disease’ that too often goes undetected – 9 out of 10 people don’t know they have it. Diagnosing
#CKD
early in primary care can make all the difference. Find out more:
We are deeply troubled by the events unfolding in
#Ukraine
and the tragic loss of life. We condemn any unprovoked attack and have been working to assist the people affected by this tragedy — protecting employees, ensuring medicines reach patients, and assisting relief efforts.
Lift off! In collaboration with
@ISS_CASIS
we’ve sent nanoparticles to the International Space Station to study drug delivery in space. We hope to make discoveries that could help improve the delivery of medicines back on Earth.
Our latest paper in
@CD_AACR
advances new approaches in immunotherapy combination strategies. Engineering dual immune checkpoint inhibition in a single molecule represents a step forward in the rational design of cancer immunotherapy.
The
#ClimateEmergency
is a public health emergency, and no one is immune. We’re honoured to be joining the
#G7Summit
today to discuss accelerating the transition to a more sustainable future together with
@TheSMI
.
@PawzLenaLuLa
@MenePangalos
@imperialcollege
"Zeneca" is an invented name, created by an agency instructed to find a name which began with a letter from either the top or bottom of the alphabet and was phonetically memorable, of no more than three syllables and did not have an offensive meaning in any language.
While the world adapts to a new normal, cancer stayed the same. Hear Dr. Adrian Kilcoyne answer the most asked questions about cancer and
#COVID19
.
#NewNormalSameCancer
Our new collaboration with Mila, the Quebec Artificial Intelligence Institute, brings together leading experts in
#AI
to scale up ideas and push the boundaries of traditional drug discovery and development using advanced computational methods:
This International Women’s Day, we’re championing the right for every girl to learn, lead and thrive, and fulfil her potential as the women and leaders of the future.
#younghealthprogramme
#choosetochallenge
#iwd2021
By 2025 we will plant 20 million trees in Indonesia as part of our AZ Forest
#reforestation
programme. This initiative supports our work to foster a healthy planet and healthy people
@Trees4Trees
@onetreeplanted
In collaboration with
@Gavi
,
@CEPIvaccines
,
@WHO
,
@UNICEF
and
@SerumInstIndia
, through the vaccine programme, we are working to provide broad, equitable access of our vaccine to 145 countries to help alter the course of the pandemic.
Read the new interim distribution forecast for information on early projected availability of doses of the Pfizer/BioNTech vaccine in Q1 2021 and the AstraZeneca/Oxford vaccine in the first half of 2021 to
#COVAX
Facility participants:
In a new
@NatureChemistry
paper with
@scrippsresearch
, we show the potential of targeting RNA with small molecules. Designing small molecules capable of interacting with and modulating RNA, could open new avenues to target challenging disease pathways.
We continue to push the boundaries of science to transform the lives of people living with asthma. Our data presented at
#AAAAI21
bring us one step closer to transforming patient care:
#Cancer
doesn’t stop during the
#COVID19
pandemic and neither do we. As
#ESMO20
moves to a virtual format, we continue our pursuit of advancing precision medicine with 114 abstracts across four of our oncology platforms to be presented during the event
While for many of us the holidays are a time to switch off, cancer doesn’t take a break. This holiday season we must spread the message with our loved ones: Don’t wait. Contact your doctor. Get checked.
#NewNormalSameCancer
Medicines and vaccines are constantly evaluated for safety to ensure benefits outweigh any potential risks. These reviews start early in medicine development, through to ongoing safety monitoring in the ‘real-world’.
#whatsciencecando
We're accelerating research on
#COVID19
therapies and partnering to boost testing to help patients in urgent need. We announced a new trial evaluating how one of our existing medicines may help alleviate the “cytokine storm” associated with this disease.
ILC2 invites grant applications for projects that go beyond prevention to support people with
#lungcancer
at different stages of diagnosis. Learn more:
#LCAM
#LungAmbition
Strong scientific progress to improve the lives of patients remains a key priority for AstraZeneca – our 2021 Q1 results demonstrate our momentum in delivering on this promise throughout the year and in the years to come. $AZN